| Economics aspects of ageing population P Marešová, H Mohelská, K Kuča Procedia economics and finance 23, 534-538, 2015 | 63 | 2015 |
| The potential of medical device industry in technological and economical context P Maresova, M Penhaker, A Selamat, K Kuca Therapeutics and clinical risk management 11, 1505, 2015 | 41 | 2015 |
| Alzheimers disease: cost cuts call for novel drugs development and national strategy. P Marešová, B Klímová, K Kuča Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a …, 2015 | 36 | 2015 |
| Výzkum uplatnění znalostního managementu v českých podnicích P Marešová Technická univerzita v Liberci, 2010 | 27 | 2010 |
| Deployment of cloud computing in small and medium sized enterprises in the Czech Republic P Marešová, V Hálek Economics and Management, 2014 | 26 | 2014 |
| Knowledge management in Czech enterprises P Maresova E & M EKONOMIE A MANAGEMENT 13 (1), 131-144, 2010 | 26 | 2010 |
| Měření ve znalostním managementu-aplikace metody Cost Benefit Analysis P Marešová Gaudeamus, 2012 | 24 | 2012 |
| The economic burden of the care and treatment for people with Alzheimer’s disease: the outlook for the Czech Republic P Marešová, V Zahálková Neurological Sciences 37 (12), 1917-1922, 2016 | 19 | 2016 |
| A comprehensive view on evaluation of cluster initiatives V Bureš, V Jašíková, T Otčenášková, K Kolerová, V Zubr, P Marešová Proceedings of the 8th European conference on management leadership and …, 2012 | 18 | 2012 |
| Cost of treatment and care for people with Alzheimer’s disease: A Meta-Analysis P Marešová, J Dolejs, H Mohelska, LK Bryan Current Alzheimer Research 16 (14), 1245-1253, 2019 | 13 | 2019 |
| Call for a uniform strategy of collecting Alzheimer’s disease costs: A review and meta-analysis P Marešová, J Dolejš, K Kuca Journal of Alzheimer's Disease 63 (1), 227-238, 2018 | 13 | 2018 |
| Cooperation policy of rare diseases in the European Union P Marešová, H Mohelská, K Kuča Procedia-Social and Behavioral Sciences 171, 1302-1308, 2015 | 13 | 2015 |
| Ethical Questions Linked to Rare Diseases and Orphan Drugs–A Systematic Review J Kacetl, P Marešová, R Maskuriy, A Selamat Risk management and healthcare policy 13, 2125, 2020 | 10 | 2020 |
| Potential of ICT for Business in the Czech Republic P Marešová Professional Publishing, 2013 | 10 | 2013 |
| Medical device development process, and associated risks and legislative aspects-systematic review P Marešová, B Klímová, J Honegr, K Kuča, WNH Ibrahim, A Selamat Frontiers in public health 8, 308, 2020 | 9 | 2020 |
| Effective evaluation of cloud computing investment: application of cost benefit method analysis P Marešová, V Soběslav Technická univerzita v Liberci, 2017 | 9 | 2017 |
| Onset of mortality increase with age and age trajectories of mortality from all diseases in the four nordic countries J Dolejs, P Marešová Clinical Interventions in Aging 12, 161, 2017 | 9 | 2017 |
| Complexity stage model of the medical device development based on economic evaluation—MedDee P Marešová, L Peter, J Honegr, L Režný, M Penhaker, M Augustýnek, ... Sustainability 12 (5), 1755, 2020 | 8 | 2020 |
| Application of the Cost Benefit Analysis method in Cloud Computing in the Czech Republic P Marešová, K Půžová Procedia-Social and Behavioral Sciences 109, 674-678, 2014 | 8 | 2014 |
| Method for evaluating the performance of clusters in the Czech Republic P Marešová, V Jašíková, M Trousil Proceedings of the 2nd International Conference on Urban sustainability …, 2011 | 8 | 2011 |
